Kappa Bioscience appoints Rena Cohen-First as vice president of sale for North America
Rena Cohen-First will be based out of the company’s New Jersey office.
Photo © iStockphoto.com/skynesher
Kappa Bioscience (Oslo, Norway) appointed Rena Cohen-First as vice president of sales North America. Previously, Cohen-First was vice president of sales at OmniActive Health for the company’s western region. She will be based out of the company’s New Jersey office.
"Kappa is a remarkable leader, truly pushing the tipping point of K2's global impact on health and wellness,” said Cohen-First in a press release. “I'm excited to work with our partners to help bring this awareness to North American consumers."
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
